TIRZEPATIDE 10MG

Description

Tirzepatide 10mg research peptide — Canada

Researched & reviewed by the SPO Quality Team · Last reviewed: 2 October 2026

Tirzepatide (LY3298176) is a 39-amino-acid synthetic peptide carrying a C20 fatty-diacid chain, built to activate both the GIP and GLP-1 receptors^[1]. This listing is a single sealed vial holding 10 mg of lyophilized research-grade tirzepatide by label, the smallest of our four strengths, for laboratory research only.

Identity at a glance

Batch documentation: A batch-specific COA for this strength has not been posted yet — see the COA library (/coa/).

What researchers have looked at

• First human data (2018): a 26-week phase 2 trial in type 2 diabetes compared LY3298176 with placebo and with dulaglutide and recorded glycaemic and body-weight endpoints^[2].
• Receptor pharmacology (2020): in cell assays it behaved as an imbalanced agonist — close to native GIP at the GIP receptor, weaker and biased toward cAMP at the GLP-1 receptor^[3].
• Structure (2022): cryo-EM structures of tirzepatide bound to GIPR and GLP-1R showed how its sequence and lipid chain set that different engagement of the two receptors^[4].
• Weight-management programme (2023): the US FDA cleared tirzepatide under the brand Zepbound for chronic weight management, a decision reported in JAMA^[5].

Regulatory status: tirzepatide is licensed as Mounjaro (type 2 diabetes) and Zepbound (chronic weight management) in the USA and elsewhere, and Health Canada lists both as prescription drugs. Those approvals cover Eli Lilly’s finished medicines and say nothing about research-grade powder.

Storage and handling

• Store the sealed vial frozen at −20 °C (site guidance: up to 24 months as lyophilized powder); keep it dry and away from light and avoid repeated freeze–thaw cycles.
• Solvents such as bacteriostatic water are sold separately; any preparation method is the researcher’s own.

Other strengths: TIRZEPATIDE 20MG, TIRZEPATIDE 50MG and TIRZEPATIDE 60MG. Shipped by Canada Post from inside Canada (shipping policy); the rest of the catalogue is on our buy peptides online in Canada page.

Frequently asked questions

Can I buy tirzepatide 10mg in Canada?

Yes. The 10mg research vial ships by Canada Post from inside Canada, so there is no customs step. It is research-grade material for laboratory use, not the prescription medicine.

Is there a COA for the 10mg vial?

Not yet. No batch-specific COA for this strength has been posted in the COA library, and we do not substitute another strength’s or product’s report. The page will be updated when one is available.

Why choose the 10mg vial over the larger ones?

It holds less labelled material, which suits short assay series or a first look at the compound. It is the same tirzepatide as the 20mg, 50mg and 60mg listings and is not described as better or worse for any purpose.

Is this Mounjaro or Zepbound?

No. Mounjaro and Zepbound are Eli Lilly’s licensed prescription medicines. This vial is unlicensed research material, is not authorised as a medicine and must not be used as one.

Cited

1. Coskun et al. (2018), Molecular metabolism — PMID 30473097
2. Frias et al. (2018), Lancet (London, England) — PMID 30293770
3. Willard et al. (2020), JCI insight — PMID 32730231
4. Sun et al. (2022), Proceedings of the National Academy of Sciences of the United States of America — PMID 35333651
5. Abbasi (2023), JAMA — PMID 37966831

For laboratory research use only. Not for human or animal consumption. No dosing, administration or protocol information is provided, and nothing here is a claim of efficacy or safety in humans.